Apogee Therapeutics Inc (NASDAQ: APGE) started the day on Wednesday, with a price increase of 18.90% at $47.24, before settling in for the price of $39.73 at the close. Taking a more long-term approach, APGE posted a 52-week range of $26.20-$63.50.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -39.80%. This publicly-traded company’s shares outstanding now amounts to $46.10 million, simultaneously with a float of $39.57 million. The organization now has a market capitalization sitting at $2.82 billion. At the time of writing, stock’s 50-day Moving Average stood at $37.84, while the 200-day Moving Average is $38.70.
Apogee Therapeutics Inc (APGE) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Apogee Therapeutics Inc’s current insider ownership accounts for 33.51%, in contrast to 83.22% institutional ownership. According to the most recent insider trade that took place on Oct 01 ’25, this organization’s Chief Medical Officer sold 5,110 shares at the rate of 39.80, making the entire transaction reach 203,378 in total value, affecting insider ownership by 284,733. Preceding that transaction, on Sep 03 ’25, Company’s Chief Medical Officer sold 2,725 for 37.87, making the whole transaction’s value amount to 103,198. This particular insider is now the holder of 233,548 in total.
Apogee Therapeutics Inc (APGE) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.44 per share during the current fiscal year.
Apogee Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -39.80% and is forecasted to reach -5.71 in the upcoming year.
Apogee Therapeutics Inc (NASDAQ: APGE) Trading Performance Indicators
Let’s observe the current performance indicators for Apogee Therapeutics Inc (APGE). It’s Quick Ratio in the last reported quarter now stands at 16.36.
In the same vein, APGE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.08, a figure that is expected to reach -1.19 in the next quarter, and analysts are predicting that it will be -5.71 at the market close of one year from today.
Technical Analysis of Apogee Therapeutics Inc (APGE)
If we take a close look at the recent performances of Apogee Therapeutics Inc (NASDAQ: APGE), its last 5-days Average volume was 0.57 million that shows plunge from its year to date volume of 0.7 million. During the previous 9 days, stock’s Stochastic %D was recorded 80.84% While, its Average True Range was 86.92.
Raw Stochastic average of Apogee Therapeutics Inc (APGE) in the period of the previous 100 days is set at 96.48%, which indicates a major fall in contrast to 97.93% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.99 that was lower than 2.04 volatility it exhibited in the past 100-days period.
